4 completed. 2 Phase 4, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Scopolamine patch: new trials by email Literature Review of Scopolamine patch trials Research Report on Scopolamine patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Analgesia Effect on Post Surgical Patient Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product - Obesity, Morbid, Surgery | Phase 4 | Completed | University of California, Davis | 60 | 2021-01-20 | 2026-09-14 |
| The Prevention and Treatment of Nausea Associated With Motion Sickness Scopolamine Nasal Gel, Placebo - Motion Sickness | Phase 3 | Completed | Repurposed Therapeutics, Inc. | 300 | 2019-04-26 | 2019-12-03 |
| The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression Placebo, Medication Therapy Management (MTM), Scopolamine patch - Alzheimer's Disease, Dementia | Early Phase 1 | Completed | Daniela Moga | 90 | 2017-04-04 | 2023-07-19 |
| Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section scopolamine patch, acupressure point P6 - Nausea, Vomiting | Phase 4 | Completed | Rutgers, The State University of New Jersey | 240 | 2016-05-01 | 2022-12-28 |
Agnosia (1) · Alzheimer Disease (1) · Dementia (1) · Motion Sickness (1) · Nausea (1) · Obesity, Morbid (1) · Personal Satisfaction (1) · Vomiting (1)
Daniela Moga (1) · Repurposed Therapeutics, Inc. (1) · Rutgers, The State University of New Jersey (1) · University of California, Davis (1)
United States (4)
Barbara Jachniewicz, MSN, CRNFA, (1) · Daniela Moga, MD, PhD (1) · Dave Helton (1) · Mohamed R Ali, MD, FACS (1) · Shaul Cohen, MD (1)
PMID 31888732, PMID 34002866, PMID 36281668, PMID 36894900
R01AG054130 (1)